Discounted Cash Flow Rating

Neutral

Return on Equity Rating

Sell

Debt to Equity Rating

Buy

Price to Earnings Rating

Strong Buy

Analyst Rating

Neutral

Upgrade To View Simple Moving Average Rating

Upgrade

Upgrade To Get Access

Upgrade To View Exponential Moving Average Rating

Upgrade

Upgrade To Get Access

Upgrade To View Relative Strength Index Rating

Upgrade

Upgrade To Get Access

Upgrade To View Standard Deviation Rating

Upgrade

Upgrade To Get Access

Upgrade To View Williams %R Rating

Upgrade

Upgrade To Get Access

Upgrade To View Average Directional Index Rating

Upgrade

Upgrade To Get Access

Upgrade To View Insider Trading Rating

Upgrade

Upgrade To Get Access

Wall Street Data Solutions Rating

Neutral

B

Oramed Pharmaceuticals Inc. (ORMP)

Pharmaceutical Preparations

https://www.oramed.com

Oramed Pharmaceuticals Inc is a pharmaceutical company which is engaged in the research and development of pharmaceutical solutions, including an oral insulin capsule to be used for the treatment of individuals with diabetes, and the use of orally ingestible capsules or pills for delivery of other polypeptides. The ORMD-0801 is a proprietary product which is an orally ingestible insulin capsule for the treatment of diabetes. Its other product includes Oral Glucagon-like peptide-1 which is an incretin hormone, a type of gastrointestinal hormone that stimulates the secretion of insulin from the pancreas.

1185 AVENUE OF THE AMERICAS, 3RD FLOOR
NEW YORK, NY

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

05/01/2007

Market Cap

96,493,638

Shares Outstanding

40,340,000

Weighted SO

40,338,979

Total Employees

N/A

Upcoming Earnings

08/08/2024

Similar Tickers

PLX --.--%

CRVS --.--%

ALDX --.--%

GMDA --.--%

CKPT --.--%

BLRX --.--%

ARDX --.--%

LXRX --.--%

MCRB --.--%

Beta

1.7840

Last Div

0.0000

Range

1.67-3.67

Chg

0.0250

Avg Vol

135158

Mkt Cap

96493638

Exch

NASDAQ

Country

US

Phone

844 967 2633

DCF Diff

2.1267

DCF

0.2481

Div Yield

0.0000

P/S

72.0102

EV Multiple

-14.7630

P/FV

0.6441

Div Yield %

0.0000

P/E

-15.4585

PEG

-5.9615

Payout

0.0000

Current Ratio

2.2476

Quick Ratio

2.2476

Cash Ratio

0.0699

DSO

0.0000

DIO

0.0000

Op Cycle

0.0000

DPO

0.0000

CCC

0.0000

Gross Margin

1.0000

Op Margin

-8.8746

Pretax Margin

-6.1254

Net Margin

-4.6373

Eff Tax Rate

0.1899

ROA

-0.0269

ROE

-0.0413

ROCE

-0.0779

NI/EBT

0.7571

EBT/EBIT

0.6902

EBIT/Rev

-8.8746

Debt Ratio

0.3292

D/E

0.5096

LT Debt/Cap

0.0026

Total Debt/Cap

0.3376

Int Coverage

15.4241

CF/Debt

-0.1168

Equity Multi

1.5482

Rec Turnover

0.0000

Pay Turnover

0.0000

Inv Turnover

0.0000

FA Turnover

0.7924

Asset Turnover

0.0058

OCF/Share

-0.2195

FCF/Share

-0.2257

Cash/Share

4.3277

OCF/Sales

-6.6246

FCF/OCF

1.0283

CF Coverage

-0.1168

ST Coverage

-0.1174

CapEx Coverage

-35.3665

Div&CapEx Cov

-35.3665

P/BV

0.6441

P/B

0.6441

P/S

72.0102

P/E

-15.4585

P/FCF

-10.5712

P/OCF

-10.8211

P/CF

-10.8211

PEG

-5.9615

P/S

72.0102

EV Multiple

-14.7630

P/FV

0.6441

DPS

0.0000

Latest Headlines (EST)

No Headlines Found

Revenue Product Segmentation